FDA Approves Expansion of BioMarin Pharma Plant

BioMarin Pharmaceutical announced the FDA approved expansion of a manufacturing facility where the company makes several of its drugs and a key experimental drug, according to a San Francisco Chronicle report.

Advertisement

The manufacturing facility, located in Novato, Calif., now has the capacity to produce $1 billion in products — twice its previous capacity.

Related Articles on Supply Chain:
Commentary: Pharmaceutical Companies More Careful About Off-Label Promotion
GE Unveils Discovery IGS 730 Interventional Imaging System at RSNA
FDA Approves Philips’ PET and MRI Whole Body Scanning System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.